Sign In
Buy RHHBY
$49.06
-0.130 (-0.264%)
At Close: Jun 03, 2026
Roche to Invest $50 Billion in U.S. Manufacturing, R&D Amid Tariff Threats
01:56am, Tuesday, 22'nd Apr 2025
The pharma giant said the investment would create more than 12,000 new jobs, as it joins rival Novartis in expanding its footprint in the country amid President Trump's tariff threats.
Roche to invest $50 billion in United States over next five years
01:10am, Tuesday, 22'nd Apr 2025
Roche on Tuesday said it will invest $50 billion in the United States over the next five years, in one of the biggest inward investment moves by companies dealing with President Donald Trump's tariffs
Roche to invest USD 50 billion in pharmaceuticals and diagnostics in the United States over the next five years
01:00am, Tuesday, 22'nd Apr 2025
Basel, 22 April 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it will invest USD 50 billion into the United States of America in the next five years. These investments further strengt
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- #biotech--Oak Hill Bio has entered into an exclusive license agreement with Roche to obtain global rights for rugonersen for Angelman syndrome.
Trump Says Pharmaceutical Tariffs Coming in Near Future
02:03pm, Monday, 14'th Apr 2025
President Donald Trump said tariffs on pharmaceuticals will be coming in the “not too distant future” and fit in the category of tariffs imposed on cars, steel, and aluminum. Trump spoke with repo
Roche Gets Nod for Expanded Use of Columvi in Lymphoma in Europe
10:55am, Monday, 14'th Apr 2025
The European Commission approves RHHBY's Columvi combo to treat adult patients with diffuse large B-cell lymphoma after initial therapy.
Basel, 14 April 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission has approved Columvi® (glofitamab) in combination with gemcitabine and oxaliplatin (GemOx) for t
Roche: Forget Tariffs And Focus On The Positives -- There Are Many
04:49pm, Friday, 11'th Apr 2025
The Trump administration's proposed tariffs on pharmaceuticals have caused significant stock declines, but their implementation remains uncertain and may be aimed at achieving specific goals. Roche's
Trump's pharmaceutical tariffs could raise costs for patients, worsen drug shortages
10:30am, Friday, 11'th Apr 2025
President Donald Trump's planned tariffs on pharmaceuticals imported into the U.S. could have wide-ranging consequences on the drug supply chain, manufacturers and American patients, some experts told
Zealand Pharma Goes on Hiring Spree as It Gears Up for Obesity Tie-Up With Roche
10:27am, Friday, 11'th Apr 2025
The Danish biotech's recruitment drive began last summer when data from an early-stage trial of the drug—petrelintide—showed its potential.
Onco-Innovations' Inka Health Publishes Roche-Sponsored Study Advancing Real-World Oncology Research
06:00pm, Thursday, 10'th Apr 2025
VANCOUVER, BC / ACCESS Newswire / April 10, 2025 / Onco-Innovations Limited (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that its subsidiary, In
Explainer: Prescription drugs become a target in Trump's trade war
02:27pm, Wednesday, 09'th Apr 2025
U.S. President Donald Trump late on Tuesday reiterated he would impose tariffs on imports of pharmaceutical products that have long been spared from past trade disputes due to the potential for harm t
Healthy Returns: Trump says major pharmaceutical tariffs coming ‘very shortly'
01:06pm, Wednesday, 09'th Apr 2025
Trump doubled down on plans to soon impose "major" pharmaceutical tariffs, while early stage startups dominated digital health funding deals in first quarter.
Why Roche Holding, Eli Lilly, and AstraZeneca Stocks Dropped Today
11:11am, Wednesday, 09'th Apr 2025
Just like the rest of the stock market, pharmaceutical stocks are in a funk approaching the midweek mark, and it's looking like things might be about to get even worse for this particular pocket of th
Roche To Start Phase 3 Study For Alzheimer's Prospect This Year After New Data From Phase 2
04:14pm, Friday, 04'th Apr 2025
Roche Holdings AG RHHBY on Thursday presented new data at the AD/PD 2025 International Conference on Alzheimer's and Parkinson's Diseases.
